These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31364825)

  • 1. Ondansetron-Induced Myoclonus With Escitalopram and HAART: Role of Drug Interactions.
    Kolli V; Addula M
    Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31364825
    [No Abstract]   [Full Text] [Related]  

  • 2. Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use.
    Kwon P; Lefkowitz W
    Pediatr Ann; 2008 Mar; 37(3):128-30. PubMed ID: 18411854
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of SSRI-associated urinary retention with mirtazapine augmentation.
    Lenze EJ
    J Clin Psychopharmacol; 2012 Jun; 32(3):434. PubMed ID: 22561481
    [No Abstract]   [Full Text] [Related]  

  • 4. Neonatal morbidity due to maternal use of two antidepressant drugs.
    Jwa S; Wada Y; Yamamoto M; Sumida Y
    Pediatr Int; 2018 Jan; 60(1):87-88. PubMed ID: 29235219
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myoclonus as a side effect to citalopram treatment in a patient with liver cirrhosis].
    Forsberg-Gillving M; Bode M; Sindrup SH
    Ugeskr Laeger; 2015 Sep; 177(39):V04150325. PubMed ID: 26418639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute maniform reaction to a single dose of escitalopram in a social phobic patient--an atypical jitteriness syndrome?
    Muhtz C; Agorastos A; Kellner M
    Pharmacopsychiatry; 2009 Nov; 42(6):291-2. PubMed ID: 19924592
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute dyskinesia and extrapyramidal disorder in a child after ingestion of escitalopram.
    Muthusami S; Basu S; Kumar A; Dash A
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):317-8. PubMed ID: 19519270
    [No Abstract]   [Full Text] [Related]  

  • 8. [SSRI-induced akathesia].
    Hofmann M; Vidoni F
    Psychiatr Prax; 1996 May; 23(3):143-4. PubMed ID: 8711007
    [No Abstract]   [Full Text] [Related]  

  • 9. Eyelash Loss Secondary to Escitalopram But Not to Sertraline: A Case Report.
    Norton DJ; Cates C
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27722027
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective serotonin re-uptake inhibitors (SSRIs) and alopecia areata.
    Ruiz-Doblado S; Carrizosa A; García-Hernández MJ; Rodríguez-Pichardo A
    Int J Dermatol; 1999 Oct; 38(10):798-9. PubMed ID: 10561061
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of citalopram on worry and brain activation in patients with generalized anxiety disorder.
    Hoehn-Saric R; Schlund MW; Wong SH
    Psychiatry Res; 2004 May; 131(1):11-21. PubMed ID: 15246451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series.
    Van Ameringen M; Mancini C; Patterson B; Bennett M
    J Psychopharmacol; 2007 Jul; 21(5):472-6. PubMed ID: 17664246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ondansetron-Induced Myoclonus With Escitalopram and Highly Active Antiretroviral Therapy: A Closer Look at 5-HT3 Receptors.
    Naguy A
    Prim Care Companion CNS Disord; 2020 Jun; 22(3):. PubMed ID: 32569451
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of ondansetron in the treatment of generalized anxiety disorder.
    Freeman AM; Westphal JR; Norris GT; Roggero BA; Webb PB; Freeman KL; Rush JA; Hearne EM; Evoniuk G
    Depress Anxiety; 1997; 5(3):140-1. PubMed ID: 9323456
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram-Induced Rash.
    Prabhakar D; Sablaban I
    Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30806996
    [No Abstract]   [Full Text] [Related]  

  • 17. Ondansetron augmentation in patients with obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: improvement with treatment and worsening following discontinuation.
    Pallanti S; Bernardi S; Antonini S; Singh N; Hollander E
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):375-80. PubMed ID: 24406025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine for the treatment of anxiety disorders in children and adolescents.
    Isaacs E
    N Engl J Med; 2001 Aug; 345(6):466-7. PubMed ID: 11496864
    [No Abstract]   [Full Text] [Related]  

  • 19. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S; Osatuke K; Aslam M; Kasckow J
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxious depression and response to treatment.
    Nelson JC
    Am J Psychiatry; 2008 Mar; 165(3):297-9. PubMed ID: 18316424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.